4Tissue raised €2M in seed funding to advance its innovative breast tissue replacement technology. Led by three female investors, this funding will help accelerate the development of 4Tissue's bioresorbable hydrogel, offering a safer, minimally invasive alternative to traditional breast reconstruction methods.
A group of scientists in Ghent is developing a material for breast reconstruction and founding a spin-off, 4Tissue, to bring their invention to patients. The first data on the development of this material, based on a basic polymer, showed promising results in vitro and in vivo. The company is currently focused on raising external funding to...
